The Government amended the Drugs Rules, 1945, to bring advanced cell, stem cell, gene therapy products, and xenografts under a uniform central regulatory system.
The amendment places these products under the Centrally Licensed Approving Authority (CLAA) for licensing and regulation.
CLAA is a division of the Central Drugs Standard Control Organisation (CDSCO), India's national drug regulatory authority.
Gene therapy products use genes to treat or prevent diseases, while stem cell-derived products are made using stem cells for medical treatment.
Xenografts are organs or tissues transplanted from one species (such as pigs) to another species (such as humans).
The amendment aims to ensure uniform regulation, safety, quality, and oversight of advanced therapies across India.